Synopsis of Key Gynecologic Oncology Trials

This book is a valuable resource for practitioners and residents in gynecologic oncology, providing a comprehensive overview of clinical trials and treatment options for uterine, ovarian, cervical, and vulvar cancers, as well as gestational trophoblastic neoplasia.

Format: Paperback / softback
Length: 160 pages
Publication date: 06 December 2022
Publisher: Taylor & Francis Ltd

This revised and updated new edition of a best-selling text remains a comprehensive and convenient overview of the clinical trials in gynecologic cancer treatment, outlining the evidence base of treatment decisions for uterine, ovarian, cervical, and vulvar cancers, as well as gestational trophoblastic neoplasia. Designed for residents and fellows, this book serves as an indispensable reference, while practitioners will welcome it as a valuable clarification of the evidence base for treatment options.

The book begins with an introduction that provides an overview of the clinical trials in gynecologic oncology, including their purpose, design, and methodology. It then proceeds to cover specific cancer types, such as uterine, ovarian, cervical, and vulvar cancers, as well as gestational trophoblastic neoplasia. Each chapter is organized in a clear and concise manner, with key points highlighted and summarized for easy reference.

Throughout the text, the evidence base for treatment decisions is extensively discussed, with a focus on randomized controlled trials (RCTs) and meta-analyses. The authors provide a comprehensive review of the literature, including the latest findings and recommendations from major clinical trials and expert consensus conferences. This evidence-based approach ensures that readers are provided with the most up-to-date and reliable information available.

In addition to the clinical trials, the book also includes a section on the role of biomarkers in gynecologic cancer treatment. Biomarkers are molecules that can be used to identify and predict the response to treatment, and they have become increasingly important in the field of oncology. The authors discuss the use of biomarkers in the diagnosis, staging, and treatment of gynecologic cancers, and they provide examples of how they are being used in clinical practice.

Another notable feature of this book is its emphasis on patient-centered care. The authors recognize that treatment decisions in gynecologic cancer are not solely based on clinical evidence, but also on the individual patient's preferences, values, and circumstances. They provide guidance on how to communicate with patients about treatment options, including the benefits and risks of each treatment, and how to help patients make informed decisions that are consistent with their goals and values.

Overall, this revised and updated new edition of a best-selling text remains a valuable resource for residents, fellows, and practitioners in gynecologic oncology. It provides a comprehensive and evidence-based overview of the clinical trials in gynecologic cancer treatment, as well as a section on the role of biomarkers and patient-centered care. With its clear and concise writing style, this book is easy to read and understand, making it an indispensable tool for anyone involved in the care of patients with gynecologic cancers.

Weight: 262g
Dimension: 151 x 229 x 15 (mm)
ISBN-13: 9781032135328
Edition number: 2 ed